APC
TECH icon

Alpine Peaks Capital’s Bio-Techne TECH Stock Holding History

Alpine Peaks Capital’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.73M Sell
66,960
-7,040
-10% -$380K 5.54% 9
2026
Q1 		$3.87M Buy
74,000
+22,500
+44% +$1.35M 3.9% 16
2025
Q4 		$3.03M Buy
51,500
+15,500
+43% +$942K 2.88% 19
2025
Q3 		$2M Buy
36,000
+14,000
+64% +$750K 1.74% 21
2025
Q2 		$1.13M Buy
22,000
+12,000
+120% +$603K 1% 22
2025
Q1 		$586K Buy
+10,000
New +$678K 0.53% 23

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Alpine Peaks Capital's TECH Position: Q2 2026 in Review

Alpine Peaks Capital reduced its Bio-Techne (TECH) stake by 9.5% in Q2 2026, selling an estimated $380K and leaving 66,960 shares worth $4.73M. The position accounts for 5.54% of the portfolio, ranked #9.

Alpine Peaks Capital first reported a position in TECH in Q1 2025 and has held it in 6 quarters since. 591 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Alpine Peaks Capital held 66,960 shares of Bio-Techne worth $4.73M as of Q2 2026.
  • Alpine Peaks Capital sold 7,040 Bio-Techne shares in Q2 2026, an estimated $380K.
  • Bio-Techne made up 5.54% of Alpine Peaks Capital's portfolio in Q2 2026, its #9 holding.
  • Alpine Peaks Capital first reported a position in Bio-Techne in Q1 2025 and has held it in 6 quarters since.
  • 591 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Alpine Peaks Capital's 13F filing for Q2 2026, filed 14 Aug 2026.